Laktobakterin Apple s Vit. Se, A, C, paketiki №10

Lactobacterin is used orally for intestinal diseases and intravaginally in obstetric-gynecological practice. The contents of the vial should be dissolved with boiled water at room temperature at a ratio of 5 ml (teaspoon) of water per 1 dose of the drug. Dissolution should be carried out as follows: pour the required amount of water into a glass (according to the number of doses indicated on the vial); open the vial, remove the cap and stopper; transfer a small amount of water from the glass to the vial; after dissolution (the drug dissolves in no more than 5 minutes, forming a homogeneous suspension of whitish-gray or yellowish-beige color), transfer the contents of the vial to the same glass and mix. One teaspoon of the drug dissolved in this way constitutes 1 dose. The dissolved drug should not be stored. The required number of doses (correspondingly teaspoons) should be taken 40-60 minutes before meals and preferably washed down with milk. For infants, the drug can be given immediately before feeding. It is recommended to accompany the treatment with the use of vitamins. For adults and children over 12 years old, it is recommended to take 5 doses 2-3 times a day. Maximum single dose – 5 doses. Maximum daily dose – 15 doses. For children with intestinal dysbiosis, the drug is used from the day of birth according to the following scheme - first half-year - 3 doses 2 times a day; - second half-year - 3 doses 3 times a day; - from 1 year to 3 years - 5 doses 2 times a day; - from 3 to 6 years - 5 doses 2-3 times a day; - from 6 to 12 years - 5 doses 2-3 times a day. Maximum single dose – 5 doses. Maximum daily dose – 15 doses. The duration of the treatment course is determined by the severity of the clinical picture, the results of bacteriological and other studies, the patient's age and is - for dysfunctions and dysbiosis of various etiologies - 3-4 weeks; - for prolonged and chronic course of dysentery, post-dysenteric colitis, follow-up treatment of convalescents after acute intestinal infections, as well as for prolonged intestinal dysfunction of unknown etiology - at least 4-6 weeks; - for nonspecific ulcerative colitis, as well as chronic colitis and enterocolitis - up to 2 months. In the absence of an effect from the use of the drug for 2 weeks, a re-examination of the gastrointestinal tract microflora and correction of the latter with other drugs depending on the result obtained is necessary. To consolidate the clinical effect obtained or in the absence of complete normalization of the microflora after the end of the treatment course, in diseases occurring with relapses, repeated treatment courses are advisable. In these cases, a re-examination of the microflora is necessary before prescribing the drug. Maintenance doses of the drug (half the daily dose) are prescribed after 2-3 weeks for 1-1.5 months. For atopic dermatitis, in children weakened by diseases of any etiology, the drug is prescribed 5 doses 2 times a day. For inflammatory diseases of the female genital area and prenatal preparation of pregnant women of the "risk" group, the drug is prescribed - for inflammatory diseases of the female genital area - 5 doses 2 times a day intravaginally for 10-12 days, starting from the 10-12th day of the menstrual cycle. - for prenatal preparation of pregnant women of the "risk" group - 5 doses 1 time a day intravaginally for 5-8 days. When used intravaginally, a sterile tampon is impregnated with the drug (5 doses) dissolved in 10 ml of water and inserted into the vagina for 2-3 hours. Treatment should be carried out under the control of the restoration of vaginal secretion purity to I-II degree, until the disappearance of clinical symptoms of inflammation and laboratory confirmation.